CrossrefInfokarte
Successful Encorafenib and Cetuximab Re-Challenge Combined With Nivolumab in BRAF V600E Mutated, Mismatch-Repair-Proficient Metastatic Colorectal Cancer – A Case Report From the AGMT mCRC Registry
Clinical Colorectal Cancer · 2026-06 · 25 (2) · 297-301
DOI: 10.1016/j.clcc.2026.01.004 ↗Abstract
Kein Abstract verfügbar.
EUVIMED